Richard Kondan
Internal Medicine · Doylestown, PANPI 1215986245
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,723 of the $5,707 with a category attached, or 82.8%. It is spread thinly across 33 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,962 and has fallen 86.0% since, to $275 in 2025. Among internal medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 336 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Sekisui Diagnostics LLC$915
- Kowa Pharmaceuticals America, Inc.$875
- Pfizer$743
- AbbVie$354
- GSK$225
- plus $1K from 27 others
What the payments were for
- Consulting fees$200%
- Speaking & faculty fees$200%
- Food & beverage$4,72383%
- Education$291%
- Gifts$91516%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 52 | $1,279 |
| Sekisui Diagnostics LLC | 3 | $915 |
| Kowa Pharmaceuticals America, Inc. | 103 | $875 |
| Pfizer | 42 | $743 |
| AbbVie(2 entities) | 27 | $354 |
| GSK | 16 | $225 |
| Novo Nordisk | 16 | $213 |
| Novartis | 8 | $116 |
| Merck | 8 | $109 |
| Eisai Inc. | 7 | $104 |
| Lilly USA, LLC | 7 | $98 |
| Amgen | 5 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $63 |
| Philips North America LLC | 4 | $60 |
| Amarin Pharma, Inc. | 4 | $58 |
| Gilead | 4 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $39 |
| Abbott | 1 | $29 |
| Boehringer Ingelheim | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Biogen | 2 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Bausch Health US, LLC | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Radius Health, Inc. | 1 | $13 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
| Medicure Pharma Inc. | 1 | $11 |
| Vertos Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEVESPI AEROSPHERE$272
- SYMBICORT$272
- BYDUREON$272
- FARXIGA$272
- ELIQUIS$121
How this compares
$5,707 in reported general payments places this provider in the 90th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Doylestown
- Mustafa NoorDoylestown$172K
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- Mohammed KidwaiBala Cynwyd$894K
- Ronak BhimaniNorristown$623K
- David GoldmannPhiladelphia$525K
- Christopher StillDanville$442K
- Jeffrey FreidLower Gwynedd$425K
- Cheryl PegusSpring House$370K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.